202 related articles for article (PubMed ID: 10049282)
1. Alternative oxidase inhibitors potentiate the activity of atovaquone against Plasmodium falciparum.
Murphy AD; Lang-Unnasch N
Antimicrob Agents Chemother; 1999 Mar; 43(3):651-4. PubMed ID: 10049282
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum: the effects of atovaquone resistance on respiration.
Suswam E; Kyle D; Lang-Unnasch N
Exp Parasitol; 2001 Aug; 98(4):180-7. PubMed ID: 11560411
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro.
Thapar MM; Gupta S; Spindler C; Wernsdorfer WH; Björkman A
Trans R Soc Trop Med Hyg; 2003; 97(3):331-7. PubMed ID: 15228254
[TBL] [Abstract][Full Text] [Related]
4. Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
Skinner-Adams TS; Fisher GM; Riches AG; Hutt OE; Jarvis KE; Wilson T; von Itzstein M; Chopra P; Antonova-Koch Y; Meister S; Winzeler EA; Clarke M; Fidock DA; Burrows JN; Ryan JH; Andrews KT
Commun Biol; 2019; 2():166. PubMed ID: 31069275
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum: cyanide-resistant oxygen consumption.
Murphy AD; Doeller JE; Hearn B; Lang-Unnasch N
Exp Parasitol; 1997 Oct; 87(2):112-20. PubMed ID: 9326886
[TBL] [Abstract][Full Text] [Related]
6. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
[TBL] [Abstract][Full Text] [Related]
7. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.
Fivelman QL; Adagu IS; Warhurst DC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4097-102. PubMed ID: 15504827
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of the antimalarial activity of atovaquone by doxycycline against Plasmodium falciparum in vitro.
Yeo AE; Edstein MD; Shanks GD; Rieckmann KH
Parasitol Res; 1997; 83(5):489-91. PubMed ID: 9197398
[TBL] [Abstract][Full Text] [Related]
9. The activity of triple combinations of antifolate biguanides, with and without folinic acid, against plasmodium falciparum in vitro.
Yeo AE; Rieckmann KH
Ann Trop Med Parasitol; 1997 Apr; 91(3):247-51. PubMed ID: 9229018
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
Basco LK
Am J Trop Med Hyg; 2003 Aug; 69(2):179-83. PubMed ID: 14506774
[TBL] [Abstract][Full Text] [Related]
11. Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.
Pimentel S; Nogueira F; Benchimol C; Quinhentos V; Bom J; Varandas L; do Rosário V; Bernardino L
Malar J; 2006 Apr; 5():30. PubMed ID: 16597338
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro.
Lütgendorf C; Rojanawatsirivet C; Wernsdorfer G; Sirichaisinthop J; Kollaritsch H; Wernsdorfer WH
Wien Klin Wochenschr; 2006; 118(19-20 Suppl 3):70-6. PubMed ID: 17131244
[TBL] [Abstract][Full Text] [Related]
13. Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro.
Edstein MD; Yeo AE; Kyle DE; Looareesuwan S; Wilairatana P; Rieckmann KH
Trans R Soc Trop Med Hyg; 1996; 90(4):418-21. PubMed ID: 8882194
[TBL] [Abstract][Full Text] [Related]
14. A mechanism for the synergistic antimalarial action of atovaquone and proguanil.
Srivastava IK; Vaidya AB
Antimicrob Agents Chemother; 1999 Jun; 43(6):1334-9. PubMed ID: 10348748
[TBL] [Abstract][Full Text] [Related]
15. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
Muehlen M; Schreiber J; Ehrhardt S; Otchwemah R; Jelinek T; Bienzle U; Mockenhaupt FP
Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
[TBL] [Abstract][Full Text] [Related]
16. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
[TBL] [Abstract][Full Text] [Related]
17. Novel Endochin-Like Quinolones Exhibit Potent
van Schalkwyk DA; Riscoe MK; Pou S; Winter RW; Nilsen A; Duffey M; Moon RW; Sutherland CJ
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094134
[TBL] [Abstract][Full Text] [Related]
18. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
McKeage K; Scott L
Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
[TBL] [Abstract][Full Text] [Related]
19. Antimalaria activity of the triple combination of proguanil, atovaquone and dapsone.
Yeo AE; Edstein MD; Rieckmann KH
Acta Trop; 1997 Sep; 67(3):207-14. PubMed ID: 9241385
[TBL] [Abstract][Full Text] [Related]
20. Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum.
Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI
Biochem Pharmacol; 1997 Apr; 53(7):943-50. PubMed ID: 9174107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
